✦ LIBER ✦

Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B

✍ Scribed by Shahinul Alam; Golam Azam; Golam Mustafa; Nooruddin Ahmad; Belalul Islam; Provat Kumar Podder; Mobin Khan

Book ID: 107593793
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 153 KB
Volume: 2
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-008-9095-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of core promoter mutations w

Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy

✍ Syed Naqui Kazim; Ranjit Chauhan; Bhudev Chandra Das; Shiv Kumar Sarin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

Overlap lamivudine treatment in patients

Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants

✍ C.-J. Liu; J.-H. Kao; P.-J. Chen; T.-C. Chen; F.-Y. Lin; M.-Y. Lai; D.-S. Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Baseline and On-Treatment Predictors for

Baseline and On-Treatment Predictors for Outcome of Chronic Hepatitis B Treatment

✍ Johannes Vermehren; Annika Kau; Stefan Zeuzem 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 158 KB

Predictors of relapse in chronic hepatit

Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy

✍ Y. Liang; J. Jiang; M. Su; Z. Liu; W. Guo; X. Huang; R. Xie; S. Ge; J. Hu; Z. Ji 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

Extended lamivudine retreatment for chro

Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy

✍ Jules L. Dienstag; Eugene R. Schiff; Mack Mitchell; Donald E. Casey Jr.; Norman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Abbreviations: HBV, hepatitis B virus; HIV, human immunodeficiency virus; HBeAg, hepatitis B e antigen; anti-HBe, antibody to HBeAg; HBsAg, hepatitis B surface antigen; ALT, alanine aminotransferase; YMDD, an amino-acid motif coded for by the polymerase gene for hepatitis B virus (Y ϭ tyrosine, M ϭ

Efficacy of lamivudine re-treatment for

Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

✍ J. W. Shin; N. H. Park; J. H. Park; J. H. Park; I. D. Jeong; S-J. Bang; K. R. Jo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB